GNLX Straddle Strategy
GNLX (Genelux Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Genelux Corporation is a clinical-stage biopharmaceutical company focused on pioneering advanced oncolytic viral immunotherapies for patients confronting aggressive and/or hard-to-treat solid tumor malignancies. Its leading experimental drug, Olvi-Vec, is a proprietary, engineered vaccinia virus strain being developed to address ovarian cancer and non-small cell lung cancer. The company is also advancing V2ACT Immunotherapy for pancreatic cancer, alongside V-VET1 for the treatment of both hematologic and solid cancers. Founded in 2001, Genelux maintains its headquarters in Westlake Village, California.
GNLX (Genelux Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $121.1M, a beta of 0.59 versus the broader market, a 52-week range of 2.29-8.535, average daily share volume of 199K, a public-listing history dating back to 2023, approximately 26 full-time employees. These structural characteristics shape how GNLX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.59 indicates GNLX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on GNLX?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
GNLX snapshot
As of August 14, 2026, spot at $2.73, ATM IV 124.30%, IV rank 32.76%, expected move 35.64%. The straddle on GNLX below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this straddle structure on GNLX specifically: GNLX IV at 124.30% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 35.64% (roughly $0.97 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GNLX expiries trade a higher absolute premium for lower per-day decay. Position sizing on GNLX should anchor to the underlying notional of $2.73 per share and to the trader's directional view on GNLX stock.
GNLX straddle setup
The GNLX straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GNLX at $2.73 on that close, the first option leg uses a $2.73 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GNLX chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GNLX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $2.73 | N/A |
| Buy 1 | Put | $2.73 | N/A |
GNLX straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
GNLX straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on GNLX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on GNLX
Straddles on GNLX are pure-volatility plays that profit from large moves in either direction; traders typically buy GNLX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
GNLX thesis for this straddle
The market-implied 1-standard-deviation range for GNLX extends from approximately $1.76 on the downside to $3.70 on the upside. A GNLX long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current GNLX IV rank near 32.76% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on GNLX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, GNLX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GNLX-specific events.
GNLX straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GNLX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GNLX alongside the broader basket even when GNLX-specific fundamentals are unchanged. Always rebuild the position from current GNLX chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on GNLX?
- A straddle on GNLX is the straddle strategy applied to GNLX (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With GNLX stock at $2.73 on the most recent close, the strikes shown on this page are snapped to the nearest listed GNLX chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are GNLX straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the GNLX straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 124.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a GNLX straddle?
- The breakeven for the GNLX straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The GNLX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 35.64%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on GNLX?
- Straddles on GNLX are pure-volatility plays that profit from large moves in either direction; traders typically buy GNLX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current GNLX implied volatility affect this straddle?
- GNLX ATM IV is at 124.30% with IV rank near 32.76%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.